NewsRamp
Sequencio Therapeutics announces two abstracts selected for SITC 2026, showcasing preclinical data on TROP2 circRNA and PD-L1/PRAME dual-antigen cancer vaccines.
about 3 hours ago
about 6 hours ago
about 6 hours ago
about 7 hours ago
about 7 hours ago
about 7 hours ago
about 7 hours ago
about 8 hours ago
about 9 hours ago
about 10 hours ago
about 10 hours ago
about 10 hours ago
7 days ago
8 days ago
8 days ago
8 days ago
9 days ago
about 6 hours ago
about 6 hours ago
about 7 hours ago
about 7 hours ago
about 7 hours ago
about 11 hours ago
about 15 hours ago
about 16 hours ago
5 days ago
6 days ago
about 3 hours ago
about 7 hours ago
about 9 hours ago
about 10 hours ago
about 11 hours ago
about 7 hours ago
about 8 hours ago
about 10 hours ago
about 10 hours ago
about 12 hours ago
about 3 hours ago
about 10 hours ago
about 10 hours ago
about 10 hours ago
about 11 hours ago
For newswires & publishers
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
